Massimo Rugge

Author PubWeight™ 139.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol 2009 3.29
2 A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 2004 2.70
3 Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology 2012 2.68
4 Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. Cell 2005 2.66
5 Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 2008 2.63
6 Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. Lancet Oncol 2008 2.32
7 HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response. Cancer Immunol Immunother 2011 2.16
8 Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg 2004 1.88
9 Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis 2004 1.66
10 Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine 2004 1.65
11 Prediction of lymph node status in superficial esophageal carcinoma. Ann Surg Oncol 2008 1.62
12 Quantification of serum levels of pepsinogens and gastrin to assess eradication of Helicobacter pylori. Clin Gastroenterol Hepatol 2010 1.58
13 Barrett's epithelium after antireflux surgery. J Gastrointest Surg 2005 1.52
14 Helicobacter pylori-negative gastritis: prevalence and risk factors. Am J Gastroenterol 2012 1.51
15 Clinical usefulness of gastric-juice analysis in 2007: the stone that the builders rejected has become the cornerstone. Gastrointest Endosc 2007 1.51
16 Definition of Barrett's esophagus dysplasia: are we speaking the same language? World J Surg 2015 1.50
17 Liver steatosis in children with chronic hepatitis C. Am J Gastroenterol 2006 1.46
18 Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men. Clin Gastroenterol Hepatol 2012 1.41
19 Helicobacter pylori eradication: are we really all equal? A controlled study in native and immigrant population. Intern Emerg Med 2010 1.40
20 Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. BMC Genomics 2013 1.39
21 Staging gastritis: an international proposal. Gastroenterology 2005 1.29
22 PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis. Virchows Arch 2011 1.28
23 MicroRNA expression profiling of male breast cancer. Breast Cancer Res 2009 1.22
24 Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake. Clin Endocrinol (Oxf) 2007 1.20
25 Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol 2012 1.18
26 Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients. Liver Transpl 2009 1.18
27 MicroRNA expression profiling in human Barrett's carcinogenesis. Int J Cancer 2011 1.17
28 Management of gastric polyps: an endoscopy-based approach. Clin Gastroenterol Hepatol 2013 1.15
29 The hyaluronic acid receptor CD44 coordinates normal and metaplastic gastric epithelial progenitor cell proliferation. J Biol Chem 2013 1.14
30 Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time? Am J Gastroenterol 2003 1.12
31 Neck emergency due to parathyroid adenoma bleeding: a case report. J Med Case Rep 2009 1.10
32 Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma. BMC Cancer 2012 1.07
33 The potential of restaging in the prediction of pathologic response after preoperative chemoradiotherapy for rectal cancer. Ann Surg Oncol 2006 1.07
34 Prospective assessment of imaging after preoperative chemoradiotherapy for rectal cancer. Surgery 2010 1.07
35 Hepatoid adenocarcinoma of the colon: what should we target? Pathol Oncol Res 2011 1.05
36 Helicobacter pylori, inflammation, oxidative damage and gastric cancer: a morphological, biological and molecular pathway. Eur J Cancer Prev 2008 1.02
37 Programmed cell death 4 protein in esophageal cancer. Oncol Rep 2010 1.01
38 The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis. Hum Pathol 2013 1.00
39 Effects of blood group antigen-binding adhesin expression during Helicobacter pylori infection of Mongolian gerbils. J Infect Dis 2011 0.99
40 Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children. Clin Chem 2008 0.99
41 Early HER2 dysregulation in gastric and oesophageal carcinogenesis. Histopathology 2012 0.98
42 The ubiquitin ligase Mindbomb 1 coordinates gastrointestinal secretory cell maturation. J Clin Invest 2013 0.96
43 Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization. Hepatology 2011 0.96
44 BRAF(K601E) mutation in a patient with a follicular thyroid carcinoma. Thyroid 2011 0.96
45 MicroRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome. Thyroid 2012 0.96
46 Autoimmune atrophic gastritis--pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol 2013 0.96
47 Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification. Eur J Endocrinol 2011 0.95
48 Anterior gradient 2 overexpression in lung adenocarcinoma. Appl Immunohistochem Mol Morphol 2012 0.95
49 Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma. Blood 2011 0.94
50 Rectal cancer neoadjuvant treatment in elderly patients. Anticancer Res 2006 0.94
51 PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis. Virchows Arch 2012 0.93
52 Helicobacter pylori CagA status, mucosal oxidative damage and gastritis phenotype: a potential pathway to cancer? Helicobacter 2003 0.93
53 Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution. Ann Surg Oncol 2011 0.93
54 Pathogenesis of Helicobacter pylori infection. Helicobacter 2012 0.92
55 Hepatic spleen nodules (HSN). Scand J Gastroenterol 2010 0.92
56 Re: CDX2 homeotic gene expression in gastric noninvasive neoplasia. Am J Surg Pathol 2004 0.91
57 Oxidative DNA damage in gastric cancer: CagA status and OGG1 gene polymorphism. Int J Cancer 2008 0.91
58 Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori. Am J Gastroenterol 2004 0.91
59 Oxidative damage, pro-inflammatory cytokines, TGF-alpha and c-myc in chronic HCV-related hepatitis and cirrhosis. World J Gastroenterol 2006 0.91
60 microRNA-145 in Barrett's oesophagus: regulating BMP4 signalling via GATA6. Gut 2012 0.91
61 BRAF in primary and recurrent papillary thyroid cancers: the relationship with (131)I and 2-[(18)F]fluoro-2-deoxy-D-glucose uptake ability. Eur J Endocrinol 2010 0.89
62 Usefulness of serum pepsinogens in Helicobacter pylori chronic gastritis: relationship with inflammation, activity, and density of the bacterium. Dig Dis Sci 2006 0.89
63 Different hemodynamic patterns of alcoholic and viral endstage cirrhosis: analysis of explanted liver weight, degree of fibrosis and splanchnic Doppler parameters. Scand J Gastroenterol 2007 0.89
64 Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis. J Clin Pathol 2010 0.88
65 The Reliability of Endoscopic Biopsies in Assessing HER2 Status in Gastric and Gastroesophageal Junction Cancer: A Study Comparing Biopsies with Surgical Samples. Transl Oncol 2013 0.88
66 The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy. Oncotarget 2013 0.88
67 CDX2 hox gene product in a rat model of esophageal cancer. J Exp Clin Cancer Res 2009 0.88
68 CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer. Endocr Connect 2013 0.88
69 Clinical practice: diagnosis and evaluation of dyspepsia. J Clin Gastroenterol 2010 0.86
70 Primary squamous cell carcinoma of the thyroid: immunohistochemical profile and literature review. Tumori 2007 0.86
71 miRNAs in precancerous lesions of the gastrointestinal tract. World J Gastroenterol 2011 0.86
72 Dietary intake of vegetables, folate, and antioxidants and the risk of Barrett's esophagus. Cancer Causes Control 2013 0.86
73 Isolated tumor cells in regional lymph nodes as relapse predictors in stage I and II colorectal cancer. J Clin Oncol 2012 0.86
74 Does Helicobacter pylori infection eradication modify peptic ulcer prevalence? A 10 years' endoscopical survey. World J Gastroenterol 2006 0.85
75 High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas. Virchows Arch 2014 0.85
76 5-fluorouracil and weekly oxaliplatin combined with radiotherapy for locally advanced rectal cancer: surgical complications and long-term results. Arch Med Res 2006 0.85
77 Trifluoroacetylated proteins in liver and plasma of guinea pigs treated with HCFC-123 and halothane. Toxicol Lett 2003 0.84
78 Role of genotyping in non-small cell lung cancer treatment: current status. Drugs 2011 0.84
79 Human epithelial growth factor receptor 2 (HER2) status in primary and metastatic esophagogastric junction adenocarcinomas. Hum Pathol 2012 0.84
80 Comparison of the diagnostic accuracy of combined elastosonography and BRAF analysis vs cytology and ultrasonography for thyroid nodule suspected of malignancy. Clin Endocrinol (Oxf) 2012 0.84
81 Oxidative DNA damage in Barrett mucosa: correlation with telomeric dysfunction and p53 mutation. Ann Surg Oncol 2013 0.83
82 Indefinite for non-invasive neoplasia lesions in gastric intestinal metaplasia: the immunophenotype. J Clin Pathol 2007 0.82
83 Magnetic resonance enterography for Crohn's disease: what the surgeon can take home. J Gastrointest Surg 2011 0.82
84 Helicobacter pylori infection in children and adults: a single pathogen but a different pathology. Helicobacter 2003 0.82
85 Assessing risks for gastric cancer: new tools for pathologists. World J Gastroenterol 2006 0.82
86 Non-invasive diagnosis of Helicobacter pylori infection: simplified 13C-urea breath test, stool antigen testing, or DNA PCR in human feces in a clinical laboratory setting? Clin Biochem 2004 0.82
87 Apert syndrome with fused thalami. Fetal Pediatr Pathol 2012 0.81
88 Neoangiogenesis in temporal bone carcinoma: the prognostic role of CD105. Otol Neurotol 2012 0.81
89 Intestinal or gastric? The unsolved dilemma of Barrett's metaplasia. Hum Pathol 2009 0.81
90 Natural course of functional dyspepsia after Helicobacter pylori eradication: a seven-year survey. Dig Dis Sci 2005 0.81
91 Secondary prevention of epidemic gastric cancer in the model of Helicobacter pylori-associated gastritis. Dig Dis 2014 0.81
92 Wilson disease: histopathological correlations with treatment on follow-up liver biopsies. World J Gastroenterol 2010 0.81
93 Long-term follow-up of Barrett's epithelium: medical versus antireflux surgical therapy. J Gastrointest Surg 2011 0.81
94 IL-4 -588C>T polymorphism and IL-4 receptor alpha [Ex5+14A>G; Ex11+828A>G] haplotype concur in selecting H. pylori cagA subtype infections. Clin Chim Acta 2007 0.81
95 Helicobacter pylori Infection, Intestinal Metaplasia, and Gastric Cancer Risk in Eastern Siberia. Helicobacter 2011 0.81
96 Mitostatin is down-regulated in human prostate cancer and suppresses the invasive phenotype of prostate cancer cells. PLoS One 2011 0.81
97 Oral bisphosphonates and the risk of Barrett's esophagus: case-control analysis of US veterans. Am J Gastroenterol 2013 0.81
98 Trefoil peptides, E-cadherin, and beta-catenin expression in sporadic fundic gland polyps: further evidence toward the benign nature of these lesions. Appl Immunohistochem Mol Morphol 2009 0.80
99 Translocation t(11;18)(q21;q21) in gastric B-cell lymphomas. Cancer Sci 2009 0.80
100 Esophageal GIST: case report of surgical enucleation and update on current diagnostic and therapeutic options. Int J Surg Pathol 2007 0.80
101 New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. Clin Chim Acta 2011 0.80
102 Investigation on the presence of polyomavirus, herpesvirus, and papillomavirus sequences in colorectal neoplasms and their association with cancer. Int J Cancer 2009 0.79
103 Pericentriolar material analyses in normal esophageal mucosa, Barrett's metaplasia and adenocarcinoma. Histol Histopathol 2010 0.79
104 Differential effects of Helicobacter pylori eradication on oxidative DNA damage at the gastroesophageal junction and at the gastric antrum. Cancer Epidemiol Biomarkers Prev 2004 0.79
105 Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2004 0.79
106 Clinical guidelines: Secondary prevention of gastric cancer. Nat Rev Gastroenterol Hepatol 2012 0.78
107 Primary rectal carcinoma in patients with stage IV resectable disease at diagnosis. Anticancer Res 2007 0.78
108 Micronuclei and broken eggs in human liver carcinogenesis. Anticancer Res 2008 0.78
109 Re: Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. J Natl Cancer Inst 2012 0.78
110 PDCD4 expression in thyroid neoplasia. Virchows Arch 2012 0.78
111 Dysplasia in inflammatory bowel diseases. Dig Liver Dis 2012 0.78
112 Lesions indefinite for intraepithelial neoplasia and OLGA staging for gastric atrophy. Am J Clin Pathol 2012 0.78
113 Galectin-3 cytotest in thyroid follicular neoplasia: a prospective, monoinstitutional study. Acta Cytol 2009 0.77
114 MicroRNA dysregulation in esophageal neoplasia: the biological rationale for novel therapeutic options. Curr Pharm Des 2013 0.77
115 The role of Helicobacter pylori in the spectrum of Barrett's carcinogenesis. Cancer Prev Res (Phila) 2009 0.77
116 The war of the worlds: metaplastic versus nonmetaplastic atrophic gastritis. Gastrointest Endosc 2011 0.77
117 Whipple's disease. Gastrointest Endosc 2004 0.77
118 The original sin of oesophageal mucosa. Dig Liver Dis 2010 0.77
119 Role of miRNA in distinguishing primary brain tumors from secondary tumors metastatic to the brain. Front Biosci (Schol Ed) 2011 0.77
120 BRAF analysis before surgery for papillary thyroid carcinoma: correlation with clinicopathological features and prognosis in a single-institution prospective experience. Clin Chem Lab Med 2016 0.77
121 Colonic phenotype of the ileum in Crohn's disease: a prospective study before and after ileocolonic resection. Inflamm Bowel Dis 2014 0.77
122 MINT31 methylation in gastric noninvasive neoplasia: potential role in the secondary prevention of gastric cancer. Eur J Cancer Prev 2012 0.76
123 Rabeprazole in a one-week eradication therapy of Helicobacter pylori: comparison of different dosages. J Gastroenterol Hepatol 2003 0.76
124 Determining therapeutic approaches in the elderly with rectal cancer. Drugs Aging 2007 0.76
125 Gastrin: from pathophysiology to cancer prevention and treatment. Eur J Cancer Prev 2014 0.76
126 Pathology of dysplasia and cancer in inflammatory bowel disease. Ann Ital Chir 2011 0.76
127 [Therapy for non-muscle invasive bladder cancer: HP-NAP]. Urologia 2012 0.76
128 Pentalogy of cantrell with complete ectopia cordis in a fetus with asplenia. Pediatr Dev Pathol 2012 0.76
129 Acute liver rejection: accuracy and predictive values of doppler US measurements--initial experience. Radiology 2005 0.76
130 Effects of interferon plus ribavirin treatment on NF-kappaB, TGF-beta1, and metalloproteinase activity in chronic hepatitis C. Mod Pathol 2006 0.76
131 Barrett's esophagus: still much to learn, but "Yes, we can!". Am J Gastroenterol 2008 0.76
132 Restorative proctocolectomy for inflammatory bowel disease: the Padova prognostic score for colitis in predicting long-term outcome and quality of life. Int J Colorectal Dis 2009 0.76
133 Anterior gradient 2 profiling in Barrett columnar epithelia and adenocarcinoma. Hum Pathol 2012 0.75
134 Regression of low-grade noninvasive neoplasia in barrett's epithelium: should we lower our guard? Ann Surg 2007 0.75
135 Pancreatic mucinous cystic tumor in Turner syndrome: How a tumor bends to a genetic disease. Int J Surg Case Rep 2013 0.75
136 Up and down regulation of apoptosis in hepatitis C virus-related liver damage. J Hepatol 2004 0.75
137 From open-type atrophic gastritis to gastritis staging. Dig Dis Sci 2011 0.75
138 Recovery of gastric function after Helicobacter pylori eradication in subjects with body atrophic gastritis: prospective 4-year study. J Gastroenterol Hepatol 2005 0.75
139 The mechanisms underlying hepatitis C virus genotype 3-mediated liver damage. J Hepatol 2003 0.75
140 OLGA can guard the barn. Am J Gastroenterol 2009 0.75
141 Asthma-like syndrome in a teenager. Pediatr Allergy Immunol 2003 0.75
142 Early epigastric pain after PPI administration: exacerbation of Helicobacter pylori corpus gastritis? Helicobacter 2004 0.75
143 Neoadjuvant chemoradiotherapy with 5-fluorouracil by bolus. Anticancer Res 2009 0.75
144 Rectal cancer adjuvant chemotherapy: when is more useful? Anticancer Res 2008 0.75
145 Role of neoadjuvant treatment in cT3N0M0 rectal cancer. Anticancer Res 2009 0.75
146 Gastric type I carcinoid: a pilot study with human G17DT immunogen vaccination. Cancer Immunol Immunother 2011 0.75
147 Somatostatin receptor type 2 (SSTR2) in bronchopulmonary carcinoids. Endocr Pathol 2010 0.75
148 Extraskeletal Myxoid Chondrosarcoma of the Foot Clinically Mimicking Plantar Fibromatosis. Am J Dermatopathol 2016 0.75
149 Barrett's Registries in Europe: report of an International Workshop. Eur J Cancer Prev 2008 0.75
150 Squamous Cellular Carcinoma Antigen Serum Determination as a Biomarker of Barrett Esophagus and Esophageal Cancer: A Phase III Study. J Clin Gastroenterol 2017 0.75
151 Hepatitis C virus reinfection in liver transplant patients: evaluation of liver damage progression with echo-color Doppler. Liver Transpl 2008 0.75
152 Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori: scratch and win. Scand J Gastroenterol 2005 0.75
153 HER-2/neu expression is consistent in primary and metastatic lung adenocarcinoma. Lung Cancer 2011 0.75
154 Features predicting unresectability in hepatoblastoma. Cancer 2007 0.75
155 Health Outcomes and Direct Healthcare Costs in Patients with Melanoma: Relationship with Level of Education. Acta Derm Venereol 2019 0.75
156 "Double trouble" or an amplification of the triploidy phenotype? Fetal Pediatr Pathol 2012 0.75
157 [Fever of unknown origin and monoclonal gammapathy with unclear significance. Report of 2 cases with different pathology and clinical course]. Ann Ital Med Int 2004 0.75